target evaluation
Phylo Adds Chugai as Second Major Japanese Pharma Customer
Phylo, Inc., a private San Francisco Bay Area AI research lab, announced on August 4 that Chugai Pharmaceutical Co., Ltd. will deploy Biomni Lab, Phylo’s agentic AI platform for biomedical research, across its drug discovery workflows. Chugai is not a startup taking a flyer on unproven software: it is a Tokyo Stock Exchange-listed pharmaceutical company,…
